Clearance Summary
VENTRIA APO A-1 ALPHA-1 LIPOTROTEIN received FDA 510(k) clearance under submission number K840830, sponsored by Ventrex Laboratories, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 1984-05-21.
- Submission: K840830
- Applicant / Sponsor: Ventrex Laboratories, Inc.
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5580
- Decision date: 1984-05-21
Classification & Regulation
This clearance is catalogued under FDA product code DER and 21 CFR 866.5580, within the Immunology review panel as a Class II device.